Pleural empyema is a rare and serious complication of pneumonia. Although it is frequently seen in children, there are only a few reports about pleural empyema in newborn infants. Here we report a case of early onset neonatal pneumonia complicated with pleural empyema. The causal microorganism was group A beta-hemolytic streptococci (GAS or Streptococcus pyogenes) presumably originating from the mother, who had a puerperal infection. The mother had fever, pelvic pain, and abnormal vaginal discharge two days after delivery and subsequent increase in the antistreptolysin O titer, suggesting streptococcus infection. The patient was successfully treated by pleural drainage in addition to synergistic antimicrobial therapy.

Download full-text PDF

Source
http://dx.doi.org/10.5578/tt.5156DOI Listing

Publication Analysis

Top Keywords

pleural empyema
16
group beta-hemolytic
8
beta-hemolytic streptococci
8
pleural
5
empyema group
4
streptococci newborn
4
newborn case
4
case report
4
report pleural
4
empyema rare
4

Similar Publications

A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan.

Antibiotics (Basel)

December 2024

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute 480-1195, Aichi, Japan.

Despite the advancements in diagnostic methods and antibiotic treatment, empyema is a critical respiratory infection, showing a high mortality rate of 10-25%. To evaluate the bacterial etiology and prognostic factors of acute empyema, we conducted this long-term retrospective cohort study at our institute between 2008 and 2022. A total of 80 patients were enrolled in this cohort.

View Article and Find Full Text PDF

Background: Fibrinopurulent thorax is a rare condition that can lead to respiratory failure. Fibroblastic decortication surgery has been shown to be an effective treatment for chronic empyema in previous studies. However, there is limited evidence supporting surgical intervention for fibrinopurulent thorax in cases of respiratory failure.

View Article and Find Full Text PDF

Objective: To compare the efficacy and safety of administering six doses of intrapleural streptokinase (SK) versus the conventional three doses, in children with empyema.

Study Design: In this open label, placebo-controlled, randomized trial, we enrolled 53 children with empyema, who received three doses of intrapleural SK. Thereafter, those without clinical improvement (n = 34) and those showing clinical improvement but having persistent pleural fluid width > 10 mm on chest ultrasonography (n = 13), were randomized to receive three additional doses of SK, or three doses of placebo (normal saline).

View Article and Find Full Text PDF

Treatment of postpneumonectomy empyema remains challenging, especially in presence of bronchopleural fistula. We analysed clinical outcome data of patients with and without bronchopleural fistula undergoing an accelerated empyema treatment concept. From November 2005 to July 2020, all patients with postpneumonectomy empyema were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!